108 related articles for article (PubMed ID: 15508433)
1. Detection of ticarcillin-clavulonic acid susceptibility with microdilution method in Citrobacter, Hafnia, Proteus and some gram negative bacteria.
Uraz G; Oncül O
Drug Metabol Drug Interact; 2004; 20(3):185-91. PubMed ID: 15508433
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
Chattopadhyay B; Hall I
Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Rittenhouse SF; Miller LA; Utrup LJ; Poupard JA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):1-6. PubMed ID: 8950521
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
Rouhan D; Le Noc P; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
[TBL] [Abstract][Full Text] [Related]
6. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
Paisley JW; Washington JA
Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
Pulverer G; Peters G; Kunstmann G
J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
[TBL] [Abstract][Full Text] [Related]
8. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
Stobberingh EE
J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
Rotstein C; Amsterdam D; Beam T; Gorzynski E
Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
[TBL] [Abstract][Full Text] [Related]
11. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
Moosdeen F; Keeble J; Williams JD
Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
[TBL] [Abstract][Full Text] [Related]
12. Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.
Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC; Pfaller MA
Antimicrob Agents Chemother; 1992 Jan; 36(1):137-43. PubMed ID: 1590679
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
Gill CJ; Ponticas S; Shungu DL; Guerriero S
Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
[TBL] [Abstract][Full Text] [Related]
14. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
Gould IM; Dent J; Wise R
J Antimicrob Chemother; 1987 Mar; 19(3):307-12. PubMed ID: 3106304
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin-clavulanic acid.
Bennett AB; Martin PA; Gottlieb SA; Govendir M
Aust Vet J; 2013 May; 91(5):171-8. PubMed ID: 23614511
[TBL] [Abstract][Full Text] [Related]
16. Ticarcillin/clavulanic acid: determination of minimal inhibitory concentrations against bacterial strains isolated from patients in intensive care units. Comparison with other agents.
Pasargiklian I; Lusco G; Paizis G; Mascheroni E
J Chemother; 1996 Apr; 8(2):113-21. PubMed ID: 8708742
[TBL] [Abstract][Full Text] [Related]
17. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
Aubert G; Dorche G; Frere A; Raby N; Denis M
Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of bacteria to a ticarcillin-clavulanic acid combination.
Sparks SE; Jones RL; Kilgore WR
Am J Vet Res; 1988 Dec; 49(12):2038-40. PubMed ID: 3239838
[TBL] [Abstract][Full Text] [Related]
19. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
[TBL] [Abstract][Full Text] [Related]
20. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
